ISR Reports analyzes company level findings based on 329 sponsor respondents asked to share their thoughts about current trends in the clinical development space.
“Agreement with the statement “My organization will run a clinical trial within the next two years where the majority of activities occur in the participant’s home” is noticeably different between large sponsors (those spending over $1B annually in R&D) and non-large sponsors.”
Read the full article at Bioprocess Online, and be sure to check out our Trends & Technology reports to find more research-based analysis of industry trends.
